Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA
News

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

-Reuters

byMichael Horton

December 14, 2022

1 minute read

-Reuters

SVB Leerink Initiates Coverage On Kymera Therapeutics with Market Perform Rating, Announces Price Target of $26

By Benzinga Newsdesk

Today, 4:57 PM

SVB Leerink analyst Mike Kratky initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Market Perform rating and announces Price Target of $26.

KYMR

5 Stocks To Watch For August 27, 2021

By Lisa Levin

Today, 4:57 PM

Some of the stocks that may grab investor focus today are: Wall Street expects Big Lots, Inc. (NYSE: BIG) to report quarterly earnings at $1.13 per share on revenue of $1.48 billion before the opening bell. Big Lots shares rose 1.4% to $55.00 in after-hours trading.

BIG

JNJ’s $260M Settlement Could Serve As Global Opioid Deal Template: Analyst

By Wayne Duggan

Today, 4:57 PM

Over the weekend, Johnson & Johnson (NYSE: JNJ) reached a major opioid litigation settlement that could have broader implications for the biopharmaceutical industry.

ABC

Wedbush Initiates Coverage On Hanesbrands with Neutral Rating, Announces Price Target of $18

By Benzinga Newsdesk

Today, 4:57 PM

Wedbush analyst Tom Nikic initiates coverage on Hanesbrands (NYSE:HBI) with a Neutral rating and announces Price Target of $18.

HBI

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

Related Posts

SVB Leerink Initiates Coverage On Kymera Therapeutics with Market Perform Rating, Announces Price Target of $26

5 Stocks To Watch For August 27, 2021

JNJ’s $260M Settlement Could Serve As Global Opioid Deal Template: Analyst

Wedbush Initiates Coverage On Hanesbrands with Neutral Rating, Announces Price Target of $18